AntiCD20 monoclonal antibody-based radioimmunotherapy of relapsed chemoresistant aggressive post-transplantation B-lymphoproliferative disorder in heart-transplant recipient.
Jaeger
Gerald
G
Department of Internal Medicine, Division of Haematology, Medical University, Graz, Austria. gerald.jaeger@meduni-graz.at
Linkesch
Werner
W
Temmel
Werner
W
Neumeister
Peter
P
D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D018951:Antigens, CD20 / Q000276:immunology; D019008:Drug Resistance, Neoplasm; D016027:Heart Transplantation / Q000009:adverse effects*; D006801:Humans; D008232:Lymphoproliferative Disorders / Q000188:drug therapy / Q000209:etiology / Q000276:immunology* / Q000532:radiotherapy*; D008297:Male; D008875:Middle Aged; D016499:Radioimmunotherapy / Q000379:methods*; D016896:Treatment Outcome
D000911:Antibodies, Monoclonal; D018951:Antigens, CD20